Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 9 of 9 descriptions
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 5 mg Montelukast | [1] Montelukast Montelukast | [1] Montelukast
Montelukast
💬1. 5 mg Montelukast
| [1] CYSLTR1 CYSLTR1 💬1. 5 mg Montelukast
| [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 98 98 💬1. 5 mg Montelukast
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) | [5] Digoxin Digoxin,Flurbiprofen, Midazolam, Montelukast, Omeprazole | [5] Digoxin
Digoxin
,Flurbiprofen , Omeprazole , Midazolam , Montelukast 💬 2. BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin)
| [25] ATP1A1 ATP1A1,ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, PTGS1, PTGS2 💬 [25] ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB ... 2. BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin)
| [49] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [49] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regula ... | [1] 46 46 💬2. BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | Montelukast | [1] Montelukast Montelukast | [1] Montelukast
Montelukast
💬3. Montelukast
| [1] CYSLTR1 CYSLTR1 💬3. Montelukast
| [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [8] 6 6, 13, 46, 61, 63, 85, 98, 228 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | Montelukast Krka | [1] Montelukast Montelukast | [1] Montelukast
Montelukast
💬4. Montelukast Krka
| [1] CYSLTR1 CYSLTR1 💬4. Montelukast Krka
| [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 6 6 💬4. Montelukast Krka
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | MONTELUKAST SODIUM | [1] Montelukast Montelukast | [1] Montelukast
Montelukast
💬5. MONTELUKAST SODIUM
| [1] CYSLTR1 CYSLTR1 💬5. MONTELUKAST SODIUM
| [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 228 228 💬5. MONTELUKAST SODIUM
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | Montelukast Teva | [1] Montelukast Montelukast | [1] Montelukast
Montelukast
💬6. Montelukast Teva
| [1] CYSLTR1 CYSLTR1 💬6. Montelukast Teva
| [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 228 228 💬6. Montelukast Teva
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | Montelukast, Flurbiprofen, Midazolam, Digoxin, Pravastatin and BMS-986142 | [6] BMS-986142 BMS-986142,Digoxin, Flurbiprofen, Midazolam, Montelukast, Pravastatin | [5] Digoxin
Digoxin
,Flurbiprofen , Midazolam , Montelukast , Pravastatin 💬 7. Montelukast, Flurbiprofen, Midazolam, Digoxin, Pravastatin and BMS-986142
| [24] ATP1A1 ATP1A1,ATP1A2, ATP1A3, ATP1A4, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HMGCR, PTGS1, PTGS2 💬 [24] ATP1A1, ATP1A2, ATP1A3, ATP1A4, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GAB ... 7. Montelukast, Flurbiprofen, Midazolam, Digoxin, Pravastatin and BMS-986142
| [49] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Terpenoid backbone biosynthesis, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [49] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secre ... | [1] 46 46 💬7. Montelukast, Flurbiprofen, Midazolam, Digoxin, Pravastatin and BMS-986142
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | Montelukast/ Singulair | [1] Montelukast Montelukast | [1] Montelukast
Montelukast
💬8. Montelukast/ Singulair
| [1] CYSLTR1 CYSLTR1 💬8. Montelukast/ Singulair
| [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 98 98 💬8. Montelukast/ Singulair
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | Singulair (Montelukast Sodium) | [1] Montelukast Montelukast | [1] Montelukast
Montelukast
💬9. Singulair (Montelukast Sodium)
| [1] CYSLTR1 CYSLTR1 💬9. Singulair (Montelukast Sodium)
| [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 228 228 💬9. Singulair (Montelukast Sodium)
|